Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03558503 |
|---|---|
| Brief Title: | A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (OPTIMA II) |
| First Submitted : | May 8, 2018 |
| First Submitted that Met QC Criteria : | June 3, 2018 |
| First Posted : | June 15, 2018 |
| Certification/Extension First Submitted : | December 9, 2020 |
| Certification/Extension First Submitted that Met QC Criteria : | December 9, 2020 |
| Certification/Extension First Posted : | December 11, 2020 |
| Last Update Submitted that Met QC Criteria : | December 9, 2020 |
| Last Update Posted : | December 11, 2020 |